| Entry date | September 24, 2002  12:00 +1GMT
  |  | Last update | December 27, 2016  14:37 +1GMT
  |  
| Allergome Code | 35
  |  
| Name | Ani s 1 
  |  
| Common Names | a3079, Serine protease inhibitor
  |  
| Biological Function | Serine Protease Inhibitors
  |  
Isoforms, Variants, Epitopes | Ani s 1.0101
  |  
Links to Molecule Sequences | Ani s 1 - L7V0K4 - UNIPROT, Ani s 1 - L7V3Q3 - UNIPROT, Ani s 1.0101 - Q7Z1K3 - UNIPROT
  |  
| Sources |  |  
Links to Source Taxonomy | Ani s - 6269 - NCBI, Ani s - 6269 - UniProt, Ani s - Discover Life, Ani s - Wikipedia
  |  
| Links to Source Images | Anisakis simplex on Google images |  | Tissues | Whole Body
  |  
| Routes of Exposure | Ingestion
  |  
Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography |  | 0 - No Criteria | 2014 | Croatia | IgE | 500 | 0.600 | 20140211, Mladineo I
	 |  | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 10.400 | 20140625, Armentia A
	 |  | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
	 |  | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 6.000 | 20140625, Armentia A
	 |  | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.000 | 20130111, Ott H
	 |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Italy | IgE | 42 | 66.700 | 20130702, Caballero ML
	 |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Spain | IgE | 35 | 85.700 | 20130702, Caballero ML
	 |  | 1.7 - Urticaria, Diagnosed | 2013 | Spain | IgE | 25 | 39.000 | 20131113, Daschner A
	 |  | 3.2.1 - Source Sensitized (IgE) | 2013 | Spain | IgE | 20 | 92.000 | 20131113, Daschner A
	 |  | 3.2.1 - Source Sensitized (IgE) | 2013 | Spain | IgE | 17 | 52.900 | 20130702, Caballero ML
	 |  | 3.2.1 - Source Sensitized (IgE) | 2013 | Italy | IgE | 15 | 26.700 | 20130702, Caballero ML
	 |  | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
	 |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 4.040 | 20110223, De Knop KJ
	 |  | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
	 |  | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
	 |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 25 | 100.000 | 20120327, Gamboa PM
	 |  | 3.1.4 - Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 10 | 100.000 | 20120327, Gamboa PM
	 |  | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
	 |  | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 3.850 | 20091121, Ebo DG
	 |  | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
	 |  | ... complete "Epidemiology from Literature" listing -> |  
  |  | References | Biochemistry / Structure / Function 2014: 20140331, Lollier V
	 - 20140331, Carballeda-Sangiao N
	 - 20140214, Rodriguez-Perez R
	 2012: 20120720, Santiago HC
	 2011: 20110406, Gonzalez-Diaz H
	 2010: 20100726, Kobayashi Y
	 - 20100128, Anadon AM
	 2008: 20080413, Ibarrola I
	 - 20080215, Kobayashi Y
	 2007: 20071015, Jenkins JA
	 - 20070531, Rodriguez-Perez R
	 2004: 20040630, Shimakura K
	 2000: 2000, Moneo I
	
  Molecular Biology 2010: 20100128, Anadon AM
	 2008: 20080413, Ibarrola I
	 - 20080215, Kobayashi Y
	 2007: 20070531, Rodriguez-Perez R
	 2004: 20040630, Shimakura K
	
  Immunochemistry / Allergenicity 2014: 20140331, Carballeda-Sangiao N
	 - 20140214, Rodriguez-Perez R
	 2010: 20100726, Kobayashi Y
	 - 20100128, Anadon AM
	 2008: 20080413, Ibarrola I
	 - 20080401, Arilla MC
	 - 20080215, Kobayashi Y
	 2007: 20070531, Rodriguez-Perez R
	 2004: 20040630, Shimakura K
	 - 20040531, Caballero ML
	 2002: 2002, Caballero ML
	 2000: 2000, Moneo I
	
  Detection - Source Extracts, Food Products, Drug Preparations 2014: 20140331, Carballeda-Sangiao N
	 2008: 20080401, Arilla MC
	
  Detection - Source Tissues 2003: 2003, Gomez-Aguado F
	 2000: 2000, Moneo I
	
  Epidemiology 2014: 20140625, Armentia A
	 - 20140211, Mladineo I
	 2013: 20131113, Lin AH
	 - 20131017, Prosperi MC
	 2012: 20120528, Patelis A
	 2011: 20111215, Alessandri C
	 - 20111214, Zheng YW
	 2009: 20090826, Ebo DG
	 2004: 20040123, Toro C
	
  Diagnosis 2014: 20140609, Rentzos G
	 - 20140604, Marth K
	 - 20140331, Rockmann H
	 - 20140324, Heaps A
	 - 20140214, Rodriguez-Perez R
	 - 20140211, Martinez-Aranguren R
	 2013: 20131113, Daschner A
	 - 20131028, Lupinek C
	 - 20131017, Prosperi MC
	 - 20130904, Barbarroja-Escudero J
	 - 20130702, Caballero ML
	 - 20130111, Ott H
	 2012: 20121030, Romano A
	 - 20121004, Bonini M
	 - 20120807, Lupinek C
	 - 20120725, Pascal M
	 - 20120720, Alessandri C
	 - 20120327, Gamboa PM
	 - 20120117, Cuellar C
	 2011: 20111011, Scala E
	 ... complete Reference listing ->
  Experimental Model - Allergic Immune Response 2014: 20141010, Cho MK
	
  Experimental Model - Inhalant-induced Diseases 2014: 20141010, Cho MK
	
  Review, Editorial, Report Citations, Other Resources 2014: 20140307, Ubeira FM
	 - 20140304, Fitzsimmons CM
	 - 20140303, Baird FJ
	 2013: 20131004, Canonica GW
	 - 20130911, Arruda LK
	 - 20130906, Simons FE
	 - 20130902, Nieuwenhuizen NE
	 2012: 20121128, Ranasinghe S
	 - 20121024, Pravettoni V
	 - 20120111, Treudler R
	 2011: 20111114, Daschner A
	 2010: 20101214, Alessandri C
	 - 20100804, Sastre J
	 2009: 20090921, Nieuwenhuizen N
	 - 20090428, Lopata AL
	 - 20090328, Ferrer M
	 2008: 20080410, Audicana MT
	 2005: 20050508, Daschner A
	 2003: 2003, Valls A
	 |  
  |